OCS Stock Price Chart
OCS Financial
Oculis Holding AG
$10.71
-4.46%
$-0.5
At close: Jun 08, 16:00:00 GMT-4
$10.76
0.47%
$0.05
Post-market: Jun 08, 20:00:00 GMT-4
Back
Oculis Holding AG (OCS) Financial
Key Stats
Prev.Close
$11.21
Open
$11.2
Day's Range
$10.52 - $11.46
52 week range
$10.76 - $34.47
Volume
1.4M
Avg.Volume
343.7K
Dividend yield
--
EPS (TTM)
-1.92
Market Cap
$548.5M
What is OCS?
Oculis Holding AG is a global biopharmaceutical company, which engages in sight and improving eye care. The company is headquartered in Zug, Zug and currently employs 49 full-time employees. The company went IPO on 2023-03-03. The firm is focused on the development of eye disease treatment for ophthalmology. The company includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The firm have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.
